Examiner Christiaan Roelofse
Grant ratio: 3.6% (6th percentile in Art Unit 1762 among examiners with at least 20 applications). Average office actions per grant: 1.50. Most common rejection type: §103.
Recently active
Last office action in data: August 2026
Examiner record
- Examiner ID
- 100494
- Primary art unit
- 1762
- Work group
- 1760
- Technology center
- 1700
- Applications
- 56
- Granted applications
- 2
- Examiner phone
- (571) 272-2825
- Supervisor
- Robert Jones
- Supervisor phone
- (571) 270-7733
Save this analysis
Download this examiner report.
Log in / Sign Up to exportPeer comparisons
| Group | Examiners | Average grant ratio | Average office actions / grant |
|---|---|---|---|
| Art Unit | 25 | 54.2% | 1.90 |
| Group | 170 | 51.2% | 2.03 |
| Tech Center | 1,792 | 44.3% | 2.14 |
| USPTO | 16,475 | 52.7% | 1.98 |
Office actions per application
| Office actions | Applications | Share of applications |
|---|---|---|
| No OA observed | 0 | 0.0% |
| 1 OA | 31 | 55.4% |
| 2 OAs | 15 | 26.8% |
| 3 OAs | 5 | 8.9% |
| 4 OAs | 5 | 8.9% |
| 5+ OAs | 0 | 0.0% |
Each application is counted once. “5+” includes all higher counts.
Grant history
Recent ratios may be lower while applications remain pending.
Yearly counts
| Year | Applications | Grants | Grant rate |
|---|---|---|---|
| 2025 | 16 | 2 | 12.5% |
| 2026 | 40 | 0 | 0.0% |
Rejections by office-action stage
| Office-action stage | Actions observed | §101 | §102 | §103 | §112 |
|---|---|---|---|---|---|
| Action 1 | 56 | 0.0% | 5.4% | 75.0% | 1.8% |
| Action 2 | 25 | 0.0% | 0.0% | 76.0% | 8.0% |
| Action 3 | 10 | 0.0% | 0.0% | 70.0% | 0.0% |
| Action 4 | 5 | 0.0% | 0.0% | 60.0% | 20.0% |
Section 101 rejections
Last 3 years: 2023-08-28–2026-08-28. All years includes every dated office action in the data.
By year
2025: August memo
0.0%
0.0%
Each bar is the percentage of office actions with a §101 rejection.
PTAB appeals
No PTAB decisions could be matched to this examiner.
Older and transferred applications may not have a reliable examiner match. Data through Aug. 27, 2026.